Clough Capital Partners’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
TS
IAM
MVP
Clough Capital Partners's PGEN Position: Q3 2017 in Review
Clough Capital Partners sold out of Precigen (PGEN) in Q3 2017, closing a stake of 129,569 shares — an estimated $3.12M sold.
Clough Capital Partners first reported a position in PGEN in Q4 2013 and held it in 15 quarters. The position peaked at $29.3M in Q4 2014. 155 funds tracked by Wall St. Rank hold PGEN as of Q3 2017.
- Clough Capital Partners reported no remaining Precigen position as of Q3 2017 after selling out during the quarter.
- Clough Capital Partners sold 129,569 Precigen shares in Q3 2017, an estimated $3.12M.
- Clough Capital Partners first reported a position in Precigen in Q4 2013 and held it in 15 quarters.
- Clough Capital Partners's Precigen position peaked at $29.3M in Q4 2014.
- 155 funds tracked by Wall St. Rank held Precigen as of Q3 2017.
Based on Clough Capital Partners's 13F filing for Q3 2017, filed 14 Nov 2017.